19-45419065-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001983.4(ERCC1):c.525+33C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,450,612 control chromosomes in the GnomAD database, including 21,052 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.18 ( 2913 hom., cov: 32)
Exomes 𝑓: 0.15 ( 18139 hom. )
Consequence
ERCC1
NM_001983.4 intron
NM_001983.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.10
Publications
59 publications found
Genes affected
ERCC1 (HGNC:3433): (ERCC excision repair 1, endonuclease non-catalytic subunit) The product of this gene functions in the nucleotide excision repair pathway, and is required for the repair of DNA lesions such as those induced by UV light or formed by electrophilic compounds including cisplatin. The encoded protein forms a heterodimer with the XPF endonuclease (also known as ERCC4), and the heterodimeric endonuclease catalyzes the 5' incision in the process of excising the DNA lesion. The heterodimeric endonuclease is also involved in recombinational DNA repair and in the repair of inter-strand crosslinks. Mutations in this gene result in cerebrooculofacioskeletal syndrome, and polymorphisms that alter expression of this gene may play a role in carcinogenesis. Multiple transcript variants encoding different isoforms have been found for this gene. The last exon of this gene overlaps with the CD3e molecule, epsilon associated protein gene on the opposite strand. [provided by RefSeq, Oct 2009]
ERCC1 Gene-Disease associations (from GenCC):
- cerebrooculofacioskeletal syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Cockayne syndrome type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 19-45419065-G-T is Benign according to our data. Variant chr19-45419065-G-T is described in ClinVar as Benign. ClinVar VariationId is 1228638.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.441 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERCC1 | NM_001983.4 | c.525+33C>A | intron_variant | Intron 5 of 9 | ENST00000300853.8 | NP_001974.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ERCC1 | ENST00000300853.8 | c.525+33C>A | intron_variant | Intron 5 of 9 | 1 | NM_001983.4 | ENSP00000300853.3 |
Frequencies
GnomAD3 genomes AF: 0.182 AC: 27587AN: 151978Hom.: 2908 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
27587
AN:
151978
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.200 AC: 31708AN: 158598 AF XY: 0.199 show subpopulations
GnomAD2 exomes
AF:
AC:
31708
AN:
158598
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.152 AC: 196985AN: 1298518Hom.: 18139 Cov.: 19 AF XY: 0.154 AC XY: 99761AN XY: 645860 show subpopulations
GnomAD4 exome
AF:
AC:
196985
AN:
1298518
Hom.:
Cov.:
19
AF XY:
AC XY:
99761
AN XY:
645860
show subpopulations
African (AFR)
AF:
AC:
6995
AN:
29726
American (AMR)
AF:
AC:
8951
AN:
35788
Ashkenazi Jewish (ASJ)
AF:
AC:
3214
AN:
24532
East Asian (EAS)
AF:
AC:
16785
AN:
35502
South Asian (SAS)
AF:
AC:
19281
AN:
77352
European-Finnish (FIN)
AF:
AC:
7233
AN:
48710
Middle Eastern (MID)
AF:
AC:
802
AN:
5502
European-Non Finnish (NFE)
AF:
AC:
124771
AN:
986750
Other (OTH)
AF:
AC:
8953
AN:
54656
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8857
17714
26570
35427
44284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4672
9344
14016
18688
23360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.182 AC: 27613AN: 152094Hom.: 2913 Cov.: 32 AF XY: 0.186 AC XY: 13824AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
27613
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
13824
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
9727
AN:
41462
American (AMR)
AF:
AC:
3052
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
442
AN:
3472
East Asian (EAS)
AF:
AC:
2358
AN:
5164
South Asian (SAS)
AF:
AC:
1272
AN:
4826
European-Finnish (FIN)
AF:
AC:
1434
AN:
10584
Middle Eastern (MID)
AF:
AC:
52
AN:
292
European-Non Finnish (NFE)
AF:
AC:
8781
AN:
68002
Other (OTH)
AF:
AC:
383
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1144
2288
3431
4575
5719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.